Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 19

Showing 19 citing articles:

Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 8
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 7
Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
Xiaoxue Lang, Xiangtao Wang, Meihua Han, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4533-4568
Open Access | Times Cited: 6
Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery
Nicholas Erickson, Mihaela Stavarache, T. Ibrahim, et al.
World Neurosurgery (2025) Vol. 194, pp. 123595-123595
Open Access
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review
Fulvio Borella, Marco Carosso, Maria Pia Chiparo, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 140-140
Open Access
Advances in preclinical and clinical studies of oncolytic virus combination therapy
Wenlong Du, Jintong Na, Liping Zhong, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas
Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts‐Riemens, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2167-2167
Open Access
Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions
Qianming Kang, Luying He, Yang Zhang, et al.
Phytomedicine (2024) Vol. 130, pp. 155684-155684
Closed Access | Times Cited: 2
Advancing non-small cell lung cancer treatment: the power of combination immunotherapies
Yuanlin Wu, Guangmao Yu, Ketao Jin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers
Emiko Sonoda, Yuya Takeuchi, Nao Ogawa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2657-2657
Open Access
Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer
Guohui Zhang, Qiang Wang, Rentao Yuan, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 730, pp. 150355-150355
Closed Access
Review of immunotherapy in non-small cell lung cancer: mechanisms, clinical applications, and future prospects
Palwasha Habib
Asia-Pacific Journal of Oncology (2024)
Open Access
Murine colon cancer derived cells exhibit heterogeneous resistance profiles against an oncolytic virus
Alejandra Larrieux, Rafael Sanjuán
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
M. Zinovieva, A. V. Ryapolova, Alexander Karabelsky, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access
Human Melanoma and Glioblastoma Cells Express Cathepsins Supporting Reovirus Moscow Strain Infection
Yu. I. Ammour, Eugenia Nikolaeva, Olesya Sagimbaeva, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1944-1944
Open Access
Optimized Directed Virus Evolution to Accelerate the Generation of Oncolytic Coxsackievirus B3 Adapted to Resistant Colorectal Cancer Cells
Leslie Elsner, Babette Dieringer, Anja Geisler, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1958-1958
Open Access
A Novel Oncolytic Virus Formulation Based on Mesenchymal Stem Cell-Derived Vesicles for Tumor Therapy
Fanjun Zeng, Yucheng Huang, Bin Xu, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 700-707
Open Access
Page 1

Scroll to top